Clinical Use of a New High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction [Proteomics and Protein Markers]

CONCLUSIONS:
The hs-cTnI-VITROS assay has at least comparable diagnostic accuracy with the currently best validated hs-cTnT and hs-cTnI assays.

ClinicalTrials.gov Identifier:
NCT00470587.

Source: Clinical Chemistry - October 28, 2019 Category: Chemistry Authors: Boeddinghaus, J., Twerenbold, R., Nestelberger, T., Koechlin, L., Wussler, D., Meier, M., Troester, V., Zimmermann, T., Badertscher, P., Wildi, K., Rubini Gimenez, M., Lopez-Ayala, P., Potlukova, E., Miro, O., Martin-Sanchez, F. J., Kawecki, D., Geigy, N. Tags: Proteomics and Protein Markers Source Type: research